From the editor: an interview with Dr. Scott Grundy.
During the American Heart Association's Scientific Sessions in November 2014, this Editor had the opportunity to interview Dr. Scott Grundy regarding the new recommendations for guideline development that was issued by the International Atherosclerosis Society. (The full document is published in this issue of the journal). In developing this report, Dr. Grundy chaired a panel of international experts who spent 1 year in consideration of new evidence and regional concerns regarding the clinical management of lipoprotein disorders and vascular disease prevention. His experience in developing the Adult Treatment Panel Reports from the National Cholesterol Education Program in the United States and his extensive research in lipoprotein physiology and related disorders makes him unique in offering the expertise for worldwide leadership in this effort.
['Grundy|Scott|S|', 'Brown|W Virgil|WV|']
D026683:Advisory Committees D000818:Animals D000924:Anticholesteremic Agents D050197:Atherosclerosis D002986:Clinical Trials as Topic D050171:Dyslipidemias D006801:Humans D017410:Practice Guidelines as Topic D014280:Triglycerides
Guidelines Lipoproteins Dyslipidemia HDL LDL